share_log

Salarius Pharmaceuticals Issued U.S. Patent No. 11,773,080 Titled "Deuterium-Enriched Isoindolinonyl-Azepanediones And Related Compounds And Methods Of Treating Medical Disorders Using Same"

Benzinga ·  Jan 16 08:16

Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues

Protein degrader portfolio now includes 17 issued patents across six patent families

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment